# PDS Biotechnology Corp > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:7670b662-f5be-456a-ae8e-2fcbb17371dc | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/pds-biotechnology-corp | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:51.162298+00:00 | | Last reviewed | 2026-10-17T04:46:51.162298+00:00 | ## Identity - Legal name: PDS Biotechnology Corp - Display name: PDS Biotechnology Corp ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T05:41:27.099915+00:00 | | Completeness | 0.409 | | Record Quality | 0.844 | | Directors | 7 | | Committees | 5 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Frank Bedu-Addo, Ph.D.: Director. Status: current. Independent: false. Since: 2019-01-01. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:5 - Gregory Freitag, J.D., C.P.A.: Director. Status: current. Independent: true. Since: 2019-01-01. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:6 - Ilian Iliev, Ph.D.: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:7 - Kamil Ali-Jackson, Esq.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:8 - Otis Brawley, M.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:9 - Stephen C. Glover: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:11 - Sir Richard Sykes: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:10 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Stephen C. Glover (member, current). committee_id=alpha:committee:pds-biotechnology-corp:audit - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Stephen C. Glover (member, current). committee_id=alpha:committee:pds-biotechnology-corp:audit-compensation-chair - Compensation (compensation). Chair: Stephen C. Glover. Members: Stephen C. Glover (chair, current); Sir Richard Sykes (member, current). committee_id=alpha:committee:pds-biotechnology-corp:compensation - Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Sir Richard Sykes (member, unknown). committee_id=alpha:committee:pds-biotechnology-corp:compensation-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Sir Richard Sykes (member, current). committee_id=alpha:committee:pds-biotechnology-corp:nominating-and-governance ## Executive leadership - Frank Bedu-Addo, Ph.D.: President, Chief Executive Officer, Principal Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:12 - Gregory L. Conn, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:13 - Kirk V. Shepard, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:14 - Lars Boesgaard: Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer [CFO]. Status: current. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:15 - Spencer Brown: Senior Vice President, General Counsel, Chief Compliance Officer [GC]. Status: current. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:16 - Stephan Toutain: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:17 ## Governance events - CEO_CHANGED: Frank Bedu-Addo, Ph.D. executive of PDS Biotechnology Corp, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:jaudl31ical13 - EXECUTIVE_APPOINTED: Gregory L. Conn, Ph.D. executive of PDS Biotechnology Corp, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1j0h38f1i6i33z - EXECUTIVE_APPOINTED: Kirk V. Shepard, M.D. executive of PDS Biotechnology Corp, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1i6d82b1idzxmr - CFO_CHANGED: Lars Boesgaard executive of PDS Biotechnology Corp, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1u7czk5zfgxpj - GC_CHANGED: Spencer Brown executive of PDS Biotechnology Corp, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:nci1bai63gi - EXECUTIVE_APPOINTED: Stephan Toutain executive of PDS Biotechnology Corp, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:jl8rei1sy5wne - DIRECTOR_APPOINTED: Ilian Iliev, Ph.D. seat on PDS Biotechnology Corp, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:nvf2291rooc5b - DIRECTOR_APPOINTED: Kamil Ali-Jackson, Esq. seat on PDS Biotechnology Corp, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:q4ie8u1mgul54 - DIRECTOR_APPOINTED: Otis Brawley, M.D. seat on PDS Biotechnology Corp, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:mwjo9nnklcih - DIRECTOR_APPOINTED: Frank Bedu-Addo, Ph.D. seat on PDS Biotechnology Corp, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:niwh8vrs1jlv - DIRECTOR_APPOINTED: Gregory Freitag, J.D., C.P.A. seat on PDS Biotechnology Corp, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1cvhfxo1vn7wl4 - DIRECTOR_APPOINTED: Stephen C. Glover seat on PDS Biotechnology Corp, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:w1n6o6c0um72 - COMMITTEE_CREATED: Audit; Compensation · Chair committee of PDS Biotechnology Corp, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:mdkple1mh71c6 - COMMITTEE_MEMBER_ADDED: Stephen C. Glover member of Audit; Compensation · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:19gekh1e19pof ## Scoped resources - `alpha://company/pds-biotechnology-corp` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record - `alpha://company/pds-biotechnology-corp/identity` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=identity - `alpha://company/pds-biotechnology-corp/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=corporate-structure - `alpha://company/pds-biotechnology-corp/board` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=board - `alpha://company/pds-biotechnology-corp/committees` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=committees - `alpha://company/pds-biotechnology-corp/leadership` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=leadership - `alpha://company/pds-biotechnology-corp/ownership` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=ownership - `alpha://company/pds-biotechnology-corp/financials` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=financials - `alpha://company/pds-biotechnology-corp/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=capital-structure - `alpha://company/pds-biotechnology-corp/compensation` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=compensation - `alpha://company/pds-biotechnology-corp/governance` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=governance - `alpha://company/pds-biotechnology-corp/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=shareholder-governance - `alpha://company/pds-biotechnology-corp/audit` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=audit - `alpha://company/pds-biotechnology-corp/legal` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=legal - `alpha://company/pds-biotechnology-corp/risk` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=risk - `alpha://company/pds-biotechnology-corp/cyber` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=cyber - `alpha://company/pds-biotechnology-corp/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=ai-governance - `alpha://company/pds-biotechnology-corp/agents` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=agents - `alpha://company/pds-biotechnology-corp/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=ecosystem - `alpha://company/pds-biotechnology-corp/events` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=events - `alpha://company/pds-biotechnology-corp/relationships` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=relationships - `alpha://company/pds-biotechnology-corp/assessments` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=assessments - `alpha://company/pds-biotechnology-corp/evidence` (contract): https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:stephen-glover","name":"Stephen C. Glover"},"source_id":"board_seats"}` - Claim alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:stephen-glover","name":"Stephen C. Glover"},"source_id":"board_seats"}` - Claim alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:sir-richard-sykes","name":"Sir Richard Sykes"},"source_id":"board_seats"}` - Claim alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:sir-richard-sykes","name":"Sir Richard Sykes"},"source_id":"board_seats"}` ## Leadership - Frank Bedu-Addo, Ph.D.: Director. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:5. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5ae3d4bbb69eee9f881d7b2cccab6e632820907ccead38597c65923c0cad07ed. - Gregory Freitag, J.D., C.P.A.: Director. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:6. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5ae3d4bbb69eee9f881d7b2cccab6e632820907ccead38597c65923c0cad07ed. - Ilian Iliev, Ph.D.: Director. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5ae3d4bbb69eee9f881d7b2cccab6e632820907ccead38597c65923c0cad07ed. - Kamil Ali-Jackson, Esq.: Director. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:8. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5ae3d4bbb69eee9f881d7b2cccab6e632820907ccead38597c65923c0cad07ed. - Otis Brawley, M.D.: Director. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5ae3d4bbb69eee9f881d7b2cccab6e632820907ccead38597c65923c0cad07ed. - Sir Richard Sykes: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5ae3d4bbb69eee9f881d7b2cccab6e632820907ccead38597c65923c0cad07ed. - Stephen C. Glover: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:11. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5ae3d4bbb69eee9f881d7b2cccab6e632820907ccead38597c65923c0cad07ed. - Frank Bedu-Addo, Ph.D.: President, Chief Executive Officer, Principal Executive Officer and Director. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:12. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5ec0a4270e3fa598f0e4091aae76540c9973e2ac1bcee20925636b742518e92b. - Gregory L. Conn, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:13. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ac9b1951b6de25864507efc83af2bf175d462930cc3f4840283d67b145e64241. - Kirk V. Shepard, M.D.: Chief Medical Officer. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:14. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eca80c40364fe417aa4908cb4bfe02e0079ab612eacaf101a24c5a8b5825a1bd. - Lars Boesgaard: Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:15. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5455eff662d34c76d8e7ca5b99558d0d1f09ab04bfc406c7a7a59db86c102d1c. - Spencer Brown: Senior Vice President, General Counsel, Chief Compliance Officer. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:16. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67fb664b02cf8be55dcb9eb35da535c9201669a5b73e59646497491353b13852. - Stephan Toutain: Chief Operating Officer. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:leadership_role:17. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0244efc72b7725980556f74b4f98cebd178d4cfcb0697ca8cc45bb1a179015a0. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Stephen C. Glover. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a7df901ce4fbc0f0a3ad38aca87b8d267a94faa5e1da8b44edfe6ad7d122529d. - Compensation: Chair Stephen C. Glover; Members Stephen C. Glover (Chair); Sir Richard Sykes. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a7df901ce4fbc0f0a3ad38aca87b8d267a94faa5e1da8b44edfe6ad7d122529d. - Nominating and Governance: Chair not stated; Members Sir Richard Sykes. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a7df901ce4fbc0f0a3ad38aca87b8d267a94faa5e1da8b44edfe6ad7d122529d. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - PDS Biotechnology Corp. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a99192fac3f935fabac95fdd6367921722513125e5ee69838e8949c00094dd2d. ## Entity Status - Public listing published. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a99192fac3f935fabac95fdd6367921722513125e5ee69838e8949c00094dd2d. ## Published Fact - US. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a99192fac3f935fabac95fdd6367921722513125e5ee69838e8949c00094dd2d. ## Committee Appointment - Stephen C. Glover: member, Audit. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a7df901ce4fbc0f0a3ad38aca87b8d267a94faa5e1da8b44edfe6ad7d122529d. - Stephen C. Glover: chair, Compensation. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a7df901ce4fbc0f0a3ad38aca87b8d267a94faa5e1da8b44edfe6ad7d122529d. - Sir Richard Sykes: member, Compensation. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a7df901ce4fbc0f0a3ad38aca87b8d267a94faa5e1da8b44edfe6ad7d122529d. - Sir Richard Sykes: member, Nominating and Governance. Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a7df901ce4fbc0f0a3ad38aca87b8d267a94faa5e1da8b44edfe6ad7d122529d. ## Security Listing - PDSB (NASDAQ). Claim: alpha:claim:company:7670b662-f5be-456a-ae8e-2fcbb17371dc:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a99192fac3f935fabac95fdd6367921722513125e5ee69838e8949c00094dd2d. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:a99192fac3f935fabac95fdd6367921722513125e5ee69838e8949c00094dd2d: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/pds-biotechnology-corp). - alpha:projection-evidence:document:5ae3d4bbb69eee9f881d7b2cccab6e632820907ccead38597c65923c0cad07ed: [PDS Biotechnology Corp DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1472091/000114036125016309/ny20044298x1_def14a.htm). - alpha:projection-evidence:document:5ec0a4270e3fa598f0e4091aae76540c9973e2ac1bcee20925636b742518e92b: [PDSB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm). - alpha:projection-evidence:document:ac9b1951b6de25864507efc83af2bf175d462930cc3f4840283d67b145e64241: [PDSB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm). - alpha:projection-evidence:document:eca80c40364fe417aa4908cb4bfe02e0079ab612eacaf101a24c5a8b5825a1bd: [PDSB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm). - alpha:projection-evidence:document:5455eff662d34c76d8e7ca5b99558d0d1f09ab04bfc406c7a7a59db86c102d1c: [PDSB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm). - alpha:projection-evidence:document:67fb664b02cf8be55dcb9eb35da535c9201669a5b73e59646497491353b13852: [PDSB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm). - alpha:projection-evidence:document:0244efc72b7725980556f74b4f98cebd178d4cfcb0697ca8cc45bb1a179015a0: [PDSB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm). - alpha:projection-evidence:a7df901ce4fbc0f0a3ad38aca87b8d267a94faa5e1da8b44edfe6ad7d122529d: [Audit](https://www.sec.gov/Archives/edgar/data/1472091/000114036125016309/ny20044298x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/pds-biotechnology-corp) - [Public Markdown](https://registry.alpha.ac/companies/pds-biotechnology-corp.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/pds-biotechnology-corp?format=jsonld) - MCP resource: `alpha://companies/pds-biotechnology-corp` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T05:41:26.881654+00:00; recorded 2026-10-17T05:41:26.881654+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.